If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Board Appointments

18 Jan 2023 07:00

RNS Number : 0474N
Plant Health Care PLC
18 January 2023
 

18 January 2023

 

PLANT HEALTH CARE plc 

("Plant Health Care" or the "Company")

 

Board Appointments

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel peptides for plant protection to global agriculture markets, is pleased to announce the appointments of Kate Coppinger and James Ede-Golightly as Non-Executive Directors.

Kate Coppinger is an experienced Non-Executive Director with an extensive background in investment banking and transaction execution. Having started her career as a research analyst at CIBC World Markets, she joined Harrison Lovegrove in 2000 and continued in her role, which focused on M&A transactions, within Standard Chartered Bank until 2020 following its acquisition of Harrison Lovegrove in 2007.

James Ede-Golightly has over twenty years of experience as a professional investor and director of growth companies. His current roles include Executive Chairman of Oxehealth and Non-Executive Director of Silence Therapeutics Plc. He co-founded Ora Capital Partners in 2006 having been an analyst at Commerzbank AG and Merrill Lynch Investment Managers. James previously served as a Non-Executive Director of Plant Health Care, between June 2013 and November 2016.

 

Chris Richards, Non-Executive Chairman of Plant Health Care, commented:

"We are delighted Kate has joined the Board. Her background in M&A and regulated industries will be an asset in terms of the Company's future product development and geographic expansion.

"In addition, it is great to welcome James back to the Company to help us capture the growth opportunities that we have identified.

"Maintaining the right balance of skills and experience on the Board is one of the keys to our continued progress. These appointments strengthen the Company and we look forward to working with Kate and James as we deliver our exciting growth proposition."

 

For further information, please contact:

 

Plant Health Care plc

Jeffrey Tweedy, Chief Executive Officer

Tel: +1 919 926 1600

Jeffrey Hovey, Chief Financial Officer

 

Cenkos Securities plc - Nomad & Broker

Neil McDonald / Pete Lynch

 

 

Tel: + (0) 131 220 9771

 

SEC Newgate (Financial Communications)

Tel:+44 (0)7540 10666

Robin Tozer / George Esmond

Email: phc@secnewgate.co.uk

 

 

The following information regarding the appointment of Kate Coppinger and James Ede-Golightly is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies:

Full Name:

Katherine Jane Coppinger

Age:

52

Shareholding in the Company:

-

 Current Directorship / Partnerships:

 iGas Energy plc

The Barnes Fund Trustee Limited

Serica Energy plc

Previous Directorship / Partnerships:

-

 

Full Name:

James Lawrence Ede-Golightly

Age:

43

Shareholding in the Company:

625,608 ordinary shares

Current Directorship / Partnerships:

Dunheved Limited

East Balkan Properties Plc

Guernsey Chamber of Commerce

Ora Global Ltd

Oxeco Limited

Oxehealth Limited

Sarossa Plc

Serendipity Capital Limited

Silent Therapeutics Plc

Previous Directorship / Partnerships:

DeepMatter Group Plc

Fermain Capital Limited

Gulfsands Petroleum Plc

Ora Limited

Oxford Advanced Surfaces Ltd

Quoram Limited (previously Quoram Plc)

 

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

About Plant Health Care plc

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADBGDBDXBDGXR
Date   Source Headline
20th Apr 20227:00 amRNSHolding(s) in Company
19th Apr 20221:46 pmRNSNotice of results and investor presentation
11th Apr 202212:52 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNew Distribution agreement with Ager Agro
14th Mar 202212:49 pmRNSHolding(s) in Company
11th Mar 202212:19 pmRNSHolding(s) in Company
3rd Feb 202212:56 pmRNSHolding(s) in Company
1st Feb 20221:16 pmEQSPlant Health Care, plc
1st Feb 20227:00 amRNS2021 Trading Statement
31st Jan 20227:00 amRNSPHC949 product registration submitted to the EPA
17th Jan 20227:00 amRNSInvestor Presentation
15th Dec 20217:00 amRNSWilbur Ellis and Plant Health Care discussion
13th Dec 20217:00 amRNSCommercial scale manufacturer for Saori
30th Nov 20214:36 pmRNSPrice Monitoring Extension
20th Oct 20216:03 pmRNSExercise of Options
22nd Sep 20217:00 amRNSNew agreement with Nutrien for Saori launch
22nd Sep 20217:00 amRNSInterim Report 30 June 2021
21st Sep 20214:41 pmRNSSecond Price Monitoring Extn
21st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSArgentina approves Harpin as a seed treatment
24th Aug 20217:00 amRNSInvestor Presentation
18th Aug 20214:41 pmRNSSecond Price Monitoring Extn
18th Aug 20214:36 pmRNSPrice Monitoring Extension
9th Aug 20211:27 pmRNSHolding(s) in Company
3rd Aug 20217:00 amRNSAdmission to the U.S. OTCQB Venture Market
27th Jul 20217:00 amRNSNew Distribution Agreement with Agrii UK
26th Jul 20217:00 amRNS2021 Half-Year Trading Statement
23rd Jul 20217:00 amRNSGrant of Options
22nd Jul 20217:00 amRNSInvestor Presentation
12th Jul 20214:40 pmRNSSecond Price Monitoring Extn
12th Jul 20214:35 pmRNSPrice Monitoring Extension
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:35 pmRNSPrice Monitoring Extension
14th Jun 20212:33 pmRNSResult of AGM
14th Jun 20217:00 amRNSGreen Economy Mark awarded
9th Jun 20214:41 pmRNSSecond Price Monitoring Extn
9th Jun 20214:35 pmRNSPrice Monitoring Extension
20th May 20217:00 amRNSInvestor Presentation
7th May 20213:50 pmRNSAnnual Report & Accounts and AGM Notice Published
30th Apr 20215:40 pmRNSHolding(s) in Company
23rd Apr 20217:00 amRNSResults for the year ended 31 December 2020
21st Apr 202111:58 amRNSHolding(s) in Company
8th Apr 20213:30 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSTotal Voting Rights
22nd Mar 20217:00 amRNSInvestor Presentation
18th Mar 20211:57 pmRNSResults of Placing and Subscription
18th Mar 20217:00 amRNSProposed Placing and Subscription
1st Mar 20217:00 amRNSSaori Trial Update
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.